Back to search

Article

Real Life Data for Relugolix/Estradiol/Norethisteroneacetate Treatment for Chronic Pelvic Pain in Endometriosis Patients

2026-08-17

Abstract excerpt

<h4>Background: </h4> /objective: Relugolix–estradiol–norethisterone acetate combination therapy (relugolix CT) was licensed for endometriosis-associated pain on the strength of two big randomized controlled trials, in which dysmenorrhea improved in 73–74% and non-cyclical pelvic pain in 58–60% of participants, with discontinuation for adverse events in about 4%. Whether this performance is reproduced outside a tr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
09c81de5-6e42-597e-a23f-38d4e1760d9b
DOI
10.20944/preprints202608.1108.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Real Life Data for Relugolix/Estradiol/Norethisteroneacetate Treatment for Chronic Pelvic Pain in Endometriosis PatientsDOI 10.20944/preprints202608.1108.v1
Differences in response to dienogest therapy among different phenotypes of endometriosis: A single-center retrospective cohort analysis.Semantic proximity
Beyond staging: Potentially divergent trajectories of pain, quality of life, and fertility in endometriosis – prospective observational cohort studySemantic proximity
Dienogest interrupts the chemokine signalling axis in endometriotic lesions with resistant signatures providing novel opportunities for personalised treatment.Semantic proximity
The Impact of Evolving Endometriosis Guidelines on Diagnosis and Observational Health StudiesSemantic proximity
Quality of life and symptoms of pain in patients with endometriomas compared to those with other endometriosis lesions: a cross-sectional studySemantic proximity
Characteristics of women diagnosed with endometriosis in England: a decade of diagnoses, 2011-2021Semantic proximity
Beyond Pain Relief: Impact of Therapeutic Strategies on Health-Related Quality of Life in Endometriosis Using the EHP-30Semantic proximity
Comparative efficacy and safety of modern treatment modalities for Genitourinary Syndrome of Menopause (GSM): A Systematic Review and Network Meta-analysis of RCTsSemantic proximity
Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause: Scientific Impact Paper No. 66 October 2021: Scientific Impact Paper No. 66.Semantic proximity
Development of an Italian National Epidemiological Register on Endometriosis based on Administrative DataSemantic proximity
Factors influencing continuation of combined oral contraceptives in women with dysmenorrhea or endometriosis: A retrospective cohort study utilizing a claims database in JapanSemantic proximity
Patient-reported outcomes after switching from brand-name to generic drospirenone/ethinylestradiol combined oral contraceptives: a questionnaire-based observational studySemantic proximity
Select a neighboring publication to make it the new centre.